About Amneal Pharmaceuticals Private Limited
Data last updated:
Amneal Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Amneal Singapore Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2006PTC048109. Its GSTIN is 24AAGCA0781K1ZP (Gujarat). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹640 Cr and a paid-up capital of ₹362.77 Cr. It was formerly known as Amneal Pharmaceuticals Company (India) Private Limited. It is led by directors including Suresh Punambhai Patel (Whole-Time Director) and Rajeev Midha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 901 – 911 Iscon Elegance Opp. Karnavati Club S.G.Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,944.87 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹160.93 Cr (net margin 5.5%) and EBITDA of ₹527.01 Cr (EBITDA margin 17.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 15% over five years.
The company has about 4,547 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 2 brands: Amneal Pharmaceuticals and Amneal. As per MCA filings, the company has satisfied charges of ₹46.29 Cr on record. Court records list 17 cases involving the company, including 8 filed by the company and 9 filed against it; 5 cases are pending. The company has 10 deals on record (5 funding rounds, 5 secondary share transfers), with disclosed funding of ₹1,009.3 Cr; the latest was in October 2021. Its 4 peer companies in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Acg Associated Capsules Private Limited with revenue of ₹3,600.7 Cr. The company has 31 MSME Form 1 returns on record between 2013 and 2024, listing 2,751 overdue payments to 383 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amneal.com.
Company details
Contact details
Amneal Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is amneal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address901 – 911 Iscon Elegance Opp. Karnavati Club S.G.Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Amneal Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Amneal Pharmaceuticals operates two associated brands: Amneal Pharmaceuticals and Amneal. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generics formulations | amneal.com | |
| A pharmaceutical company manufacturing generics, specialty drugs, and AvKare products. | amnealindia.com |
Business activity
The main business activities of Amneal Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Amneal Pharmaceuticals Private Limited, buy the company report.
Financials of Amneal Pharmaceuticals Private Limited
FY 2024 filings availableAmneal Pharmaceuticals Private Limited reported revenue of ₹2,944.87 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 6% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹527.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹160.93 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.9% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amneal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amneal Pharmaceuticals Private Limited
Amneal Pharmaceuticals has 5 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Midha Also directs: Amneal Oncology Private Limited, Raks Pharma Private Limited, Amneal Healthcare Private Limited and 2 more | Director | 25 Jan 2019 | 7 Years 9 Months | Current |
| Kanubhai Punambhai Patel | Director | 17 Nov 2007 | 18 Years 11 Months | Current |
| Suresh Punambhai Patel Also directs: Kayura Effect LLP, Shivanka Research Private Limited, Amneal Oncology Private Limited and 5 more | Whole-Time Director | 07 Apr 2006 | 20 Years 7 Months | Current |
| Rahul Maitra Also directs: Amneal Oncology Private Limited, Raks Pharma Private Limited, Amneal Healthcare Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
| Sandeep Radhakisan Raktate Also directs: Amneal Oncology Private Limited, Raks Pharma Private Limited, Amneal Healthcare Private Limited and 3 more | Director | 14 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Amneal Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acg Associated Capsules Private Limited | ₹3,600.7 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Shreya Life Sciences Private Limited | ₹2,946.23 Cr (FY 2025) | 284.0% | Mumbai, Maharashtra, India | |||
| Amneal Pharmaceuticals Private Limitedthis company | ₹2,944.87 Cr (FY 2025) | ₹160.93 Cr | 5.5% | 6.0% | 4,547 | Ahmedabad, Gujarat, India |
| Sandoz Private Limited | ₹2,778.2 Cr (FY 2025) | -2.0% | Navi Mumbai, Maharashtra, India | |||
| Biological E. Limited | ₹2,708 Cr (FY 2024) | -30.0% | Telangana, India |
To see the full peer comparison of Amneal Pharmaceuticals Private Limited, buy the company report.
Auditor
Amneal Pharmaceuticals Private Limited is audited by Chandulal M. Shah & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chandulal M. Shah & Co. | FY 2024 | 101698W |
Shareholding
The shareholding of Amneal Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amneal Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2012 | 10396254 | Bank of Baroda | ₹7.99 Lakh | Satisfied | |
| 18 Jun 2012 | 10363286 | Bank of Baroda | ₹8.35 Lakh | Satisfied | |
| 02 Mar 2012 | 10345560 | Bank of Baroda | ₹15.23 Lakh | Satisfied | |
| 30 Jan 2012 | 10335600 | Bank of Baroda | ₹14.34 Lakh | Satisfied | |
| 06 Jul 2011 | 10300873 | Bank of Baroda | ₹6.6 Lakh | Satisfied |
To see the full charge records of Amneal Pharmaceuticals Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Amneal Pharmaceuticals Private Limited has 10 deals on record (5 funding rounds, 5 secondary share transfers), with disclosed funding of ₹1,009.3 Cr; the latest was in October 2021.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Funding round | ₹711.94 Cr | Investors: Amneal Pharmaceuticals Private Limited |
| May 2019 | Secondary share transfer | Undisclosed | Buyer: Amneal Pharmaceuticals Private Limited Seller: an individual |
| Jan 2019 | Secondary share transfer | Undisclosed | Buyer: Amneal Pharmaceuticals Private Limited Seller: 3 individuals |
| Apr 2014 | Funding round | ₹226.13 Cr | Investors: Amneal Pharmaceuticals Private Limited |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Amneal Pharmaceuticals Private Limited Seller: Amneal Pharmaceuticals LLC |
To see the full deal history of Amneal Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amneal Pharmaceuticals Private Limited has 17 court cases on record: 8 filed by Amneal Pharmaceuticals, 9 filed against it. 5 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 8 | 3 |
| High courts | 6 | 0 | 2 |
| NCLT | 1 | 0 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (2406-Indirect Taxation : Goods and Services Tax, Integrated Goods and Services Tax, State Goods and Services Tax, UT Goods and Services Tax.) | Filed against the company by Union of India and 161 others | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against M/S, Meliorate Engineers Pvt Ltd and 2 others | Pending |
| District court, South East, Delhi | Commercial suit | Filed against the company by M/S Flaktgroup India Pvt. Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against , Ahmedabad and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Court case (REFER-T-LC) | Filed against the company by an individual | Pending |
To see the full case history of Amneal Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Amneal Pharmaceuticals Private Limited was last rated by Care on 22 Apr 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 22 Apr 2020 |
To see the full credit ratings and regulatory alerts of Amneal Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
Amneal Pharmaceuticals Private Limited has 31 MSME Form 1 returns on record between 2013 and 2024, listing 2,751 overdue payments to 383 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 383)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Stavan International LLP | |||
| Fayme Engineering | |||
| H S Clearing Agency | |||
| an individual supplier | |||
| Alphacore Technologies Private Limited |
To see the full MSME payment records of Amneal Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Amneal Pharmaceuticals has 3 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Amneal Oncology Private Limited | U24230GJ1998PTC084755 | |
| Amneal Healthcare Private Limited | U24239GJ2021PTC123168 | |
| Amneal Biosciences Private Limited | U24299GJ2022PTC131073 |
To see the full group structure of Amneal Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Amneal Pharmaceuticals Private Limited has a workforce of 4,547 employees on its EPFO records as of Feb 18, 2025, across 1 active EPFO establishment.
GST
Amneal Pharmaceuticals has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCA0781K1ZP | Gujarat | Active | 01 Jul 2017 |
| 24AAGCA0781K2ZO | Gujarat | Active | 06 Jul 2017 |
| 24AAGCA0781K3ZN | Gujarat | Active | 12 Jul 2017 |
| 24AAGCA0781K4ZM | Gujarat | Active | 29 Sep 2017 |
To see the full GST registrations and return filing status of Amneal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amneal Pharmaceuticals Private Limited has 17 board changes on record since 2006: 5 appointments and 12 cessations. The latest: Rahul Maitra ceased to be Additional Director on 29 Sep 2024.
29 earlier events are in the company report.
News
Frequently asked questions
Amneal Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 April 2006 (20+ years old) and is registered under CIN U24231GJ2006PTC048109.
Amneal Pharmaceuticals has 5 current directors:
- Suresh Punambhai Patel - Whole-Time Director
- Rajeev Midha - Director
- Kanubhai Punambhai Patel - Director
- Rahul Maitra - Director
- Sandeep Radhakisan Raktate - Director
The latest financial statements of Amneal Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Amneal Pharmaceuticals is 24AAGCA0781K1ZP, registered in Gujarat. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 24AAGCA0781K2ZO (Gujarat), 24AAGCA0781K3ZN (Gujarat), 24AAGCA0781K4ZM (Gujarat).
The CIN (Corporate Identification Number) of Amneal Pharmaceuticals is U24231GJ2006PTC048109. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amneal Pharmaceuticals has 17 court cases on record: 8 filed by the company and 9 filed against it. 5 are pending. Most are in the district courts.
Amneal Pharmaceuticals was incorporated on 07 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Amneal Pharmaceuticals has 10 deals on record (5 funding rounds, 5 secondary share transfers), with disclosed funding of ₹1,009.3 Cr; the latest was in October 2021.
The peers of Amneal Pharmaceuticals by revenue are Acg Associated Capsules Private Limited, Shreya Life Sciences Private Limited, Sandoz Private Limited, Biological E. Limited, all in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Maitra ceased to be Additional Director on 29 Sep 2024. Sandeep Radhakisan Raktate ceased to be Additional Director on 29 Sep 2024. Rahul Maitra was appointed as Director on 14 May 2024. Amneal Pharmaceuticals has 17 board changes on record in total.
Amneal Pharmaceuticals has 31 MSME Form 1 returns on record between 2013 and 2024, listing 2,751 overdue payments to 383 micro and small suppliers. The latest return was filed on 01 May 2024.
Amneal Pharmaceuticals can be reached through the website amneal.com. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
